In the News
Congresswoman DelBene Visit Turns Spotlight on Role of NIH, Medicare/Medicaid Funding
“Across the country, Americans are suffering from heartbreaking medical conditions. If we are serious about breaking new ground in our understanding of complex diseases like Alzheimer’s, it’s absolutely essential we boost investments in medical research,” said Congresswoman Suzan DelBene (WA-01) in a statement for the Alzheimer's Association International Conference 2017 happening now in London. “That’s why I’ve called for increased funding in life-saving research at NIH to accelerate development of the next generation of treatments and cures, many of which are being developed right here in Washington state.”
As a vocal advocate for robust national funding for Alzheimer's disease research, DelBene wants a deep understanding about how our NIH-funded work furthers the first goal of the National Plan to Address Alzheimer’s Disease — preventing and effectively treating Alzheimer’s by 2025. She needs quick ways to communicate to her colleagues about the role of Medicare and Medicaid to patients, caregivers, and medical research centers—without getting into the weeds. Last week, the UW Alzheimer's Disease Research Center (ADRC) had the privilege of hosting the Congresswoman and her aide for an informational tour. The Alzheimer's Association WA State Chapter co-organized the visit.